Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4651 - 4675 of 5976 in total
A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.
Experimental
Illicit
Matched Iupac: … 6-(dimethylamino)-4,4-diphenylheptan-3-yl acetate …
Experimental
Matched Iupac: … (2S)-2-amino-6-(dimethylamino)hexanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-6-(carboxyamino)hexanoic acid …
Experimental
Matched Iupac: … (2R,5S,6R)-6-methyloxane-2,5-diol …
MK-212 has been used in trials studying the treatment of Alcoholism.
Investigational
Matched Iupac: … 2-chloro-6-(piperazin-1-yl)pyrazine …
Penclomedine has been used in trials studying the treatment of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine …
Experimental
Matched Iupac: … [azaniumyl({2-[(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)dihydroxymethyl]-1H-1,3-benzodiazol-6-yl})methylidene …
Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.[A19218,A19219,A19220]
Investigational
Matched Iupac: … ethyl 4-[(6-carbamimidamidohexanoyl)oxy]benzoate …
Oxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol.
Investigational
TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction).
Investigational
Matched Iupac: … 3-[(3R,3aR,5aS,6R,7E,9aS,9bS)-7-(hydroxyimino)-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-dodecahydro ... -1H-cyclopenta[a]naphthalen-6-yl]propan-1-ol …
Experimental
Matched Iupac: … hexaaza-8-ruthena-8,8',8''-spiroter[tricyclo[7.4.0.0^{2,7}]tridecane]-1,1',1'',3,3',3'',5,5',5'',10,10',10
Experimental
Matched Iupac: … (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(6-methyl-1H-1,3-benzodiazol-2-yl)oxane-3,4,5-triol …
Experimental
Matched Iupac: … 2-butanoyl-6-[(3-butanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5 …
Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-[(2-{[2-(4 …
Experimental
Matched Iupac: … 6-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione …
Experimental
Matched Iupac: … 6-amino-2-methylheptan-2-ol …
Experimental
Matched Iupac: … 2-[5-(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-6-hydroxy-[1,1'-biphenyl]-3-yl]ethan-1-aminium …
Experimental
Matched Iupac: … 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-methyl-1H-pyrazol-5-yl]-6-ethylbenzene-1,3-diol …
JNJ-38877605 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Iupac: … 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline …
Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
Investigational
Matched Iupac: … 6-[8-({4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]pyrazin-2-amine …
Nanatinostat is under investigation in clinical trial NCT00697879 (Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours).
Investigational
Matched Iupac: … 2-[(1R,5S,6R)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine …
Investigational
Displaying drugs 4651 - 4675 of 5976 in total